No CDC Level 4 “Avoid All Travel” notices are active as of early June 2026, with the agency’s official notices page confirming zero entries at that threshold. Recent health alerts remain at Level 1 or 2 for dengue across 16 countries and polio circulation in parts of Africa and Asia, while Ebola monitoring in the Democratic Republic of the Congo has prompted enhanced screening but not a Level 4 designation. These contained outbreaks and lower-tier precautions reflect current epidemiological data showing no extreme, unmitigable global health risks meeting the criteria for a highest-level notice before year-end. Trader consensus at 76.5% against issuance aligns with the absence of rapid escalation signals in official surveillance.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日はい
$71,851 Vol.
$71,851 Vol.
2026/12/31
はい
$71,851 Vol.
$71,851 Vol.
2026/12/31
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.No CDC Level 4 “Avoid All Travel” notices are active as of early June 2026, with the agency’s official notices page confirming zero entries at that threshold. Recent health alerts remain at Level 1 or 2 for dengue across 16 countries and polio circulation in parts of Africa and Asia, while Ebola monitoring in the Democratic Republic of the Congo has prompted enhanced screening but not a Level 4 designation. These contained outbreaks and lower-tier precautions reflect current epidemiological data showing no extreme, unmitigable global health risks meeting the criteria for a highest-level notice before year-end. Trader consensus at 76.5% against issuance aligns with the absence of rapid escalation signals in official surveillance.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
マーケット開始日： Jan 19, 2026, 3:15 PM ET
音量
$71,851終了日
2026/12/31マーケット開始日
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.No CDC Level 4 “Avoid All Travel” notices are active as of early June 2026, with the agency’s official notices page confirming zero entries at that threshold. Recent health alerts remain at Level 1 or 2 for dengue across 16 countries and polio circulation in parts of Africa and Asia, while Ebola monitoring in the Democratic Republic of the Congo has prompted enhanced screening but not a Level 4 designation. These contained outbreaks and lower-tier precautions reflect current epidemiological data showing no extreme, unmitigable global health risks meeting the criteria for a highest-level notice before year-end. Trader consensus at 76.5% against issuance aligns with the absence of rapid escalation signals in official surveillance.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
音量
$71,851終了日
2026/12/31マーケット開始日
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...No CDC Level 4 “Avoid All Travel” notices are active as of early June 2026, with the agency’s official notices page confirming zero entries at that threshold. Recent health alerts remain at Level 1 or 2 for dengue across 16 countries and polio circulation in parts of Africa and Asia, while Ebola monitoring in the Democratic Republic of the Congo has prompted enhanced screening but not a Level 4 designation. These contained outbreaks and lower-tier precautions reflect current epidemiological data showing no extreme, unmitigable global health risks meeting the criteria for a highest-level notice before year-end. Trader consensus at 76.5% against issuance aligns with the absence of rapid escalation signals in official surveillance.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問